AbbVie Balance Sheet Health
Financial Health criteria checks 3/6
AbbVie has a total shareholder equity of $6.1B and total debt of $71.3B, which brings its debt-to-equity ratio to 1174.8%. Its total assets and total liabilities are $143.4B and $137.4B respectively. AbbVie's EBIT is $17.3B making its interest coverage ratio 9. It has cash and short-term investments of $7.3B.
Key information
1,174.8%
Debt to equity ratio
US$71.32b
Debt
| Interest coverage ratio | 9x |
| Cash | US$7.29b |
| Equity | US$6.07b |
| Total liabilities | US$137.35b |
| Total assets | US$143.42b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ABBV's short term assets ($27.8B) do not cover its short term liabilities ($43.1B).
Long Term Liabilities: ABBV's short term assets ($27.8B) do not cover its long term liabilities ($94.3B).
Debt to Equity History and Analysis
Debt Level: ABBV's net debt to equity ratio (1054.8%) is considered high.
Reducing Debt: ABBV had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: ABBV's debt is well covered by operating cash flow (23.1%).
Interest Coverage: ABBV's interest payments on its debt are well covered by EBIT (9x coverage).